{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T20:09:36Z","timestamp":1764878976036,"version":"3.46.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,4]]},"DOI":"10.7759\/cureus.98467","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T20:07:02Z","timestamp":1764878822000},"source":"Crossref","is-referenced-by-count":0,"title":["Anticoagulation-Related Dilemma: A Thrombocytopenic Patient With Numerous Thrombogenic Risk Factors"],"prefix":"10.7759","author":[{"given":"Timothy","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Trube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan O","family":"Rodriguez-Padilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parker","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah","family":"Kosnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Abreu-Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200208000-00015","article-title":"Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome","volume":"30","author":"Strauss R","year":"2002","unstructured":"Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med. 2002, 30:1765-71. 10.1097\/00003246-200208000-00015","journal-title":"Crit Care Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1246283","article-title":"Venous thromboembolic disease in the intensive care unit","volume":"31","author":"Chan CM","year":"2010","unstructured":"Chan CM, Shorr AF. Venous thromboembolic disease in the intensive care unit. Semin Respir Crit Care Med. 2010, 31:39-46. 10.1055\/s-0029-1246283","journal-title":"Semin Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-1444","article-title":"Omission of early thromboprophylaxis and mortality in critically ill patients: a multicenter registry study","volume":"140","author":"Ho KM","year":"2011","unstructured":"Ho KM, Chavan S, Pilcher D. Omission of early thromboprophylaxis and mortality in critically ill patients: a multicenter registry study. Chest. 2011, 140:1436-46. 10.1378\/chest.11-1444","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(20)30400-X","article-title":"Anticoagulant and antiplatelet treatment in cancer patients with thrombocytopenia","volume":"191","author":"Leader A","year":"2020","unstructured":"Leader A, Gurevich-Shapiro A, Spectre G. Anticoagulant and antiplatelet treatment in cancer patients with thrombocytopenia. Thromb Res. 2020, 191:68-73. 10.1016\/S0049-3848(20)30400-X","journal-title":"Thromb Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-017-1478-0","article-title":"Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study","volume":"43","author":"Mantha S","year":"2017","unstructured":"Mantha S, Miao Y, Wills J, Parameswaran R, Soff GA. Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study. J Thromb Thrombolysis. 2017, 43:514-8. 10.1007\/s11239-017-1478-0","journal-title":"J Thromb Thrombolysis"},{"key":"ref6","article-title":"","author":"Myers DJ","year":"2023","unstructured":"Myers DJ, Wallen JM. Lung Adenocarcinoma. StatPearls Publishing, Treasure Island, FL; 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519578\/."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0530","article-title":"Prospective assessment of clinical risk factors and biomarkers of hypercoagulability for the identification of patients with lung adenocarcinoma at risk for cancer-associated thrombosis: the observational ROADMAP-CAT study","volume":"23","author":"Syrigos K","year":"2018","unstructured":"Syrigos K, Grapsa D, Sangare R, et al.. Prospective assessment of clinical risk factors and biomarkers of hypercoagulability for the identification of patients with lung adenocarcinoma at risk for cancer-associated thrombosis: the observational ROADMAP-CAT study. Oncologist. 2018, 23:1372-81. 10.1634\/theoncologist.2017-0530","journal-title":"Oncologist"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2020.103825","article-title":"Risk factors associated with deep venous thrombosis in patients with different bed-rest durations: a multi-institutional case-control study","volume":"114","author":"Cao J","year":"2021","unstructured":"Cao J, Li S, Ma Y, et al.. Risk factors associated with deep venous thrombosis in patients with different bed-rest durations: a multi-institutional case-control study. Int J Nurs Stud. 2021, 114:103825. 10.1016\/j.ijnurstu.2020.103825","journal-title":"Int J Nurs Stud"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp2023658","article-title":"Atrial fibrillation","volume":"384","author":"Michaud GF","year":"2021","unstructured":"Michaud GF, Stevenson WG. Atrial fibrillation. N Engl J Med. 2021, 384:353-61. 10.1056\/NEJMcp2023658","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.000000000000004","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"130","author":"January CT","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, et al.. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2014, 130:4-6. 10.1161\/CIR.000000000000004","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1749185","article-title":"Risk of thromboembolic events in cancer patients treated with immune checkpoint inhibitors: a meta-analysis of randomized controlled trials","volume":"122","author":"Ma Z","year":"2022","unstructured":"Ma Z, Sun X, Zhang Y, Li H, Sun D, An Z, Zhang Y. Risk of thromboembolic events in cancer patients treated with immune checkpoint inhibitors: a meta-analysis of randomized controlled trials. Thromb Haemost. 2022, 122:1757-66. 10.1055\/s-0042-1749185","journal-title":"Thromb Haemost"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189410","article-title":"Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer","volume":"12","author":"Kim ES","year":"2017","unstructured":"Kim ES, Baran AM, Mondo EL, et al.. Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer. PLoS One. 2017, 12:e0189410. 10.1371\/journal.pone.0189410","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-02426-9","article-title":"Postmarketing safety evaluation of pemetrexed using FAERS and JADER databases","volume":"15","author":"Lv L","year":"2025","unstructured":"Lv L, Wu X, Ren Y, Guo Y, Wang H, Li X. Postmarketing safety evaluation of pemetrexed using FAERS and JADER databases. Sci Rep. 2025, 15:18738. 10.1038\/s41598-025-02426-9","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/426902-anticoagulation-related-dilemma-a-thrombocytopenic-patient-with-numerous-thrombogenic-risk-factors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T20:07:03Z","timestamp":1764878823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/426902-anticoagulation-related-dilemma-a-thrombocytopenic-patient-with-numerous-thrombogenic-risk-factors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.98467","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,4]]}}}